Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linong Ji

Showing results (31-40 of 587) with videos related to

Pageof 59
Sort By:
Journal of Diabetes|January 8, 2019
Associations between metformin use and vitamin B<sub>12</sub> levels, anemia, and neuropathy in patients with diabetes: a meta-analysisWenjia Yang, Xiaoling Cai, Haiya Wu, et al.
Plos One|July 9, 2016
Clinical Characteristics of Young Type 2 Diabetes Patients with AtherosclerosisWenjia Yang, Xiaoling Cai, Xueyao Han, et al.
Chinese Medical Journal|October 16, 2014
Understanding the standard of care in the treatment of type 2 diabetes in China: results from a national surveyLinong Ji, Julliana Newman, Juming Lu, et al.
Endocrine Connections|August 23, 2021
Development and validation of a risk score model for prediction of lower extremity arterial disease in Chinese with type 2 diabetes aged over 50 yearsXiaomei Zhang, Zhangrong Xu, Xingwu Ran, et al.
Diabetes Technology & Therapeutics|August 11, 2018
Disparities in the Efficacy of Metformin in Combination with Dipeptidyl Peptidase-4 Inhibitor as Initial Treatment Stratified by Dosage and Ethnicity: A Meta-AnalysisXiaoling Cai, Xueying Gao, Wenjia Yang, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|March 19, 2020
Loss of HNF1α Function Contributes to Hepatocyte Proliferation and Abnormal Cholesterol Metabolism via Downregulating miR-122: A Novel Mechanism of MODY3Mengdie Hu, Xiuting Huang, Xueyao Han, et al.
Diabetes, Obesity & Metabolism|October 7, 2025
Addressing unmet needs for chronic kidney disease treatment in type 1 diabetes: A reviewKatherine R Tuttle, Linong Ji, Chantal Mathieu, et al.
Diabetes Research and Clinical Practice|November 8, 2011
The 3C study: coverage cost and care of type 1 diabetes in China--study design and implementationHelen McGuire, Katarzyna Kissimova-Skarbek, David Whiting, et al.
Nature Reviews. Endocrinology|December 4, 2019
Chinese Famine and the diabetes mellitus epidemicPaul Zimmet, Zumin Shi, Assam El-Osta, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|October 24, 2015
National Variations in Comorbidities, Glycosylated Hemoglobin Reduction, and Insulin Dosage in Asian Patients with Type 2 Diabetes: The FINE-Asia RegistryLinong Ji, Shih-Tzer Tsai, Jay Lin, et al.
Pageof 59

Showing results (31-40 of 587) with videos related to

Sort By:
Pageof 59
Journal of Diabetes|January 8, 2019
Associations between metformin use and vitamin B<sub>12</sub> levels, anemia, and neuropathy in patients with diabetes: a meta-analysisWenjia Yang, Xiaoling Cai, Haiya Wu, et al.
Plos One|July 9, 2016
Clinical Characteristics of Young Type 2 Diabetes Patients with AtherosclerosisWenjia Yang, Xiaoling Cai, Xueyao Han, et al.
Chinese Medical Journal|October 16, 2014
Understanding the standard of care in the treatment of type 2 diabetes in China: results from a national surveyLinong Ji, Julliana Newman, Juming Lu, et al.
Endocrine Connections|August 23, 2021
Development and validation of a risk score model for prediction of lower extremity arterial disease in Chinese with type 2 diabetes aged over 50 yearsXiaomei Zhang, Zhangrong Xu, Xingwu Ran, et al.
Diabetes Technology & Therapeutics|August 11, 2018
Disparities in the Efficacy of Metformin in Combination with Dipeptidyl Peptidase-4 Inhibitor as Initial Treatment Stratified by Dosage and Ethnicity: A Meta-AnalysisXiaoling Cai, Xueying Gao, Wenjia Yang, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|March 19, 2020
Loss of HNF1α Function Contributes to Hepatocyte Proliferation and Abnormal Cholesterol Metabolism via Downregulating miR-122: A Novel Mechanism of MODY3Mengdie Hu, Xiuting Huang, Xueyao Han, et al.
Diabetes, Obesity & Metabolism|October 7, 2025
Addressing unmet needs for chronic kidney disease treatment in type 1 diabetes: A reviewKatherine R Tuttle, Linong Ji, Chantal Mathieu, et al.
Diabetes Research and Clinical Practice|November 8, 2011
The 3C study: coverage cost and care of type 1 diabetes in China--study design and implementationHelen McGuire, Katarzyna Kissimova-Skarbek, David Whiting, et al.
Nature Reviews. Endocrinology|December 4, 2019
Chinese Famine and the diabetes mellitus epidemicPaul Zimmet, Zumin Shi, Assam El-Osta, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|October 24, 2015
National Variations in Comorbidities, Glycosylated Hemoglobin Reduction, and Insulin Dosage in Asian Patients with Type 2 Diabetes: The FINE-Asia RegistryLinong Ji, Shih-Tzer Tsai, Jay Lin, et al.
Pageof 59